Physician profile
Omar Said
NPI 1437481397
$29,003.58
in general payments reported to CMS, 2019-2025
50 companies · $3,919 in 2025
The $3,919 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,997 · 2020: $2,665 · 2021: $3,107 · 2022: $5,565 · 2023: $5,493 · 2024: $5,259 · 2025: $3,919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,708.65 |
| Travel and Lodging | $961.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,949.74 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $1,933.53 | 2019-2024 | Senza |
| Medtronic, INC. | $1,829.74 | 2021-2025 | Intellis Adaptivestim, Venaseal, Kyphon Express II Kyphopak Tray |
| Biotronik Nro, INC. | $1,576.29 | 2023-2025 | Prospera, Biotronik |
| Abbvie INC. | $1,565.90 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Boston Scientific Corporation | $1,471.19 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Spinal Simplicity, LLC | $1,212.40 | 2021-2025 | Ha Minuteman G3-R |
| Pfizer INC. | $930.13 | 2019-2025 | |
| Lilly USA, LLC | $834.71 | 2019-2024 | Emgality, Reyvow |
| Teva Pharmaceuticals USA, INC. | $494.34 | 2019-2021 | |
| Pacira Therapeutics, INC. | $453.79 | 2019-2021 | |
| Terumo Bct, INC. | $409.78 | 2019-2022 | |
| Amgen INC. | $377.65 | 2019-2022 | |
| Zyla Life Sciences, INC. | $304.30 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $266.61 | 2019-2021 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Said listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.